DSM-Firmenich AG against Solvay SA — live side-by-side technical comparison.
Prices as of 2026-09-23T15:35:23+00:00 UTC · updates daily
DSFIR.AS leads 4 of the 5 windows we measure — over 1 month DSFIR.AS is +4.8% and SLVYY -3.4%; over year to date DSFIR.AS is +39.3% and SLVYY -8.9%.
| DSFIR.AS | SLVYY | |
|---|---|---|
| Price | $95.76 | $2.85 |
| 1 day | -1.4% | -0.7%lead |
| 5 days | +4.3%lead | -2.1% |
| 1 month | +4.8%lead | -3.4% |
| 6 months | +64.8%lead | -0.3% |
| Year to date | +39.3%lead | -8.9% |
| 52-week position | 96% of range | 13% of range |
| 52-week range | $55.22–$97.36 | $2.77–$3.38 |
| vs 50-day average | above $90.70 | below $2.96 |
| vs 200-day average | above $73.33 | below $3.04 |
| RSI (14) | 56 | 41 |
| Next earnings | 2026-07-30 | 2025-07-29 |
DSFIR.AS trades at $95.76, above its 50-day average of $90.70, and above the 200-day at $73.33. It sits at 96% of its 52-week range ($55.22–$97.36); 14-day RSI is 56, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $97.12 (1.4% away) and the first support below is $90.70 (5.3% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
SLVYY trades at $2.85, below its 50-day average of $2.96, and below the 200-day at $3.04. It sits at 13% of its 52-week range ($2.77–$3.38); 14-day RSI is 41, in neutral territory; an average session moves it about 1.8%. For levels, the first level overhead is $2.89 (1.4% away) and the first support below is $2.77 (2.8% down). On the checklist the page runs for every asset, 0 of 6 checks read bullish — the lean is bearish.
DSFIR.AS is the more volatile of the two — an average session moves it 2.3% against 1.8% for SLVYY, so an identical position size carries roughly 1.3× the daily risk.
The comparison turns on those levels: DSFIR.AS clearing $97.12 or losing $90.70; SLVYY clearing $2.89 or losing $2.77. Until one of them gives way, the relative reading above stands.